MPLX LP vs UnitedHealth Group Inc — how do they compare? MPLX LP trades at $60.05 (market cap $61.06B), while UnitedHealth Group Inc trades at $394.25 (market cap $352.81B). The key difference: UnitedHealth Group Inc is far larger — about 5.8× MPLX LP's market cap, and MPLX LP pays the higher dividend (7.15%). Which is the better fit depends on your goals.
| MPLX | UNH | |
|---|---|---|
Market Cap | $61.06B | $352.81B |
Sector | Technology | Health |
52-Week High | $60.51 | $436.35 |
52-Week Low | $47.80 | $259.02 |
Enterprise Value | $86.17B | $394.67B |
Dividend Yield | 7.15% | 2.36% |
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $59.83, up 0.27% with strong technical momentum as moving averages signal bullish conditions. The company demonstrates robust profitability with 40.45% net income margin and 33.95% ROE, though recent Q2 2026 earnings matched expectations without beating. Analyst consensus remains strongly bullish with 19 buy ratings and a $64.00 price target, representing 7% upside potential. Recent news highlights management's commitment to 12.5% annual distribution growth through 2027.
MPLX offers attractive income with 7%+ yield and distribution growth potential, supported by fee-based midstream operations. Key risks include rising leverage approaching 4x and exposure to energy market volatility. The stock presents a compelling value proposition for income-focused investors seeking energy infrastructure exposure with growth catalysts from ongoing capacity expansions.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Trailing returns across standard periods
Latest headlines on both assets
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →